Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...

Stryker SYK has outperformed the market over ... The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of ...

Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment ...

Stryker Corporation (NYSE:SYK) reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $4.01, compared to the forecasted ...

Most readers would already be aware that Stryker's (NYSE:SYK) stock increased significantly by 11% over the past ...